Mark Donohue | Vice President, Investor Relations and Corporate Communications |
Rob Stewart | President and Chief Executive Officer |
Todd Branning | Chief Financial Officer |
Paul Bisaro | Executive Chairman |
Andy Boyer | Executive Vice President, Commercial Operations |
Joe Todisco | Senior Vice President of Specialty Commercial |
David Buchen | Chief Labor Officer and Corporate Secretary |
Randall Stanicky | RBC Capital Markets |
David Risinger | Morgan Stanley |
Louise Chen | Cantor Fitzgerald |
Chris Schott | JPMorgan |
Dana Flanders | Goldman Sachs |
Gary Nachman | BMO Capital Markets |
David Amsellem | Piper Jaffray |
Elliot Wilbur | Raymond James |
Tim Chiang | BTIG |
Dewey Steadman | Canaccord |
Good morning, and welcome to the Amneal Pharmaceuticals Fourth Quarter and Full Year 2018 Earnings Conference Call. All participants will be in listen-only mode. [Operator Instructions] After today’s presentation there will be an opportunity to ask questions. [Operator Instructions] Please note that this event is being recorded. At this time, I would like to turn the conference over to Mark Donohue, Vice President of Investor Relations and Corporate Communications.